Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report
Background: The development of drugs directed against tumor necrosis factor (TNF)-α has dramatically modified the therapeutic approach to inflammatory bowel diseases: a larger use of such drugs has also led to a major knowledge about their adverse effects, especially on skin. The aim of this report...
Main Authors: | Valentina Giorgio, Elisa Blasi, Donato Rigante, Cristina Guerriero, Clara De Simone, Anna Laura Fedele, Giuseppe Stella, Antonio Gasbarrini, Franco Scaldaferri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/18/13/6711 |
Similar Items
-
Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis
by: Alkim Unal Cakiter, et al.
Published: (2017-04-01) -
Acute hemorrhagic edema: Rare variety of leukocytoclastic vasculitis
by: Gaurav Ameta
Published: (2016-01-01) -
Leukocytoclastic vasculitis in transplant recipients: A case series of 7 patients
by: Muneeb Ilyas, BSc, et al.
Published: (2017-07-01) -
Drug-induced leukocytoclastic vasculitis: tigecycline a rare cause
by: Kalpana Bhairavarasu, et al.
Published: (2015-01-01) -
Warfarin-induced leukocytoclastic vasculitis and proteinuria
by: Khalid Jumean, et al.
Published: (2016-01-01)